Open Access Open Access  Restricted Access Subscription Access

Ketamine: Resurgence in Neuropathic Pain Management


Affiliations
1 Yenepoya Medical College, Mangaluru, India

After nearly half a century on the market,ketamine still occupies a unique corner in the medical armamentarium of anesthesiologists or clinicians treating pain.

Sub-anaesthetic doses of ketamine have been used effectively as either a primary analgesic or analgesic adjuvant in a variety of pain syndromes.The purpose of this article is to review the current useful applications of ketamine in a rather unique case.The wonder drug Ketamine was used in infusion form to produce analgesia along with sciatic nerve block for a complete patient satisfaction after failed conservative management.


Keywords

Ketamine, Neuropathic Pain, NMDA Receptor Antagonist.
User
Notifications
Font Size

  • Ketamine use in current clinical practice, Mei Gao,DamoonRejaei and Hong Liu, Acta Pharmacol Sin. 2016 Jul; 37(7): 865–872
  • Low Dose Ketamine as an Analgesic Adjuvant in Difficult Pain Syndromes, Edward J Fitzgibbon et al,Journal of pain and symptom management, February 2002Volume 23, Issue 2, Pages 165–170

Abstract Views: 147




  • Ketamine: Resurgence in Neuropathic Pain Management

Abstract Views: 147  | 

Authors

R. M. Ramyashree
Yenepoya Medical College, Mangaluru, India
Rammurthy Kulkarni
Yenepoya Medical College, Mangaluru, India

Abstract


After nearly half a century on the market,ketamine still occupies a unique corner in the medical armamentarium of anesthesiologists or clinicians treating pain.

Sub-anaesthetic doses of ketamine have been used effectively as either a primary analgesic or analgesic adjuvant in a variety of pain syndromes.The purpose of this article is to review the current useful applications of ketamine in a rather unique case.The wonder drug Ketamine was used in infusion form to produce analgesia along with sciatic nerve block for a complete patient satisfaction after failed conservative management.


Keywords


Ketamine, Neuropathic Pain, NMDA Receptor Antagonist.

References





DOI: https://doi.org/10.18311/isacon-Karnataka%2F2017%2FEP032